Intravenous Ketamine Relieves Pain and Depression After Traumatic Suicide Attempts: A Case Series

J Clin Psychopharmacol. 2018 Apr;38(2):149-150. doi: 10.1097/JCP.0000000000000852.

Authors

Nicholas Mischel¹, Christian Bjerre-Real, Jonathan Komisar, Brian Ginsberg, Steven T Szabo, Xavier PreudʼHomme

Affiliation

¹ Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC Nicholas.mischel@duke.edu; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC; Department of Anesthesiology, Duke University, Durham, NC; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC and Durham VA Medical Center, Durham, NC; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC.

PMID: 29424806
DOI: 10.1097/JCP.0000000000000852

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Intravenous
Aged
Aged, 80 and over
Analgesics / administration & dosage
Analgesics / pharmacology*
Antidepressive Agents / administration & dosage
Antidepressive Agents / pharmacology*
Depressive Disorder, Major / drug therapy*
Humans
Ketamine / administration & dosage
Ketamine / pharmacology*
Male
Pain / drug therapy*
Pain / etiology
Self-Injurious Behavior* / complications
Suicide Prevention*

Substances

Analgesics
Antidepressive Agents
Ketamine